235 related articles for article (PubMed ID: 2501330)
21. Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora.
Kauffman CA; Liepman MK; Bergman AG; Mioduszewski J
Am J Med; 1983 Apr; 74(4):599-607. PubMed ID: 6837588
[No Abstract] [Full Text] [Related]
22. Prospective randomly controlled trial of three antibiotic combinations for empirical therapy of suspected sepsis in neutropenic cancer patients.
Gaya H; Klastersky J; Schimpff SC; Fière D; Widmaier S; Nagel G
Eur J Cancer (1965); 1975 Aug; 11suppl():5-8. PubMed ID: 767119
[No Abstract] [Full Text] [Related]
23. Management of fever in neutropenic patients.
Bodey GP; Rolston KV
J Infect Chemother; 2001 Mar; 7(1):1-9. PubMed ID: 11406750
[TBL] [Abstract][Full Text] [Related]
24. Overview of empiric antibiotic therapy for the febrile neutropenic patient.
Schimpff SC
Rev Infect Dis; 1985; 7 Suppl 4():S734-40. PubMed ID: 3878564
[TBL] [Abstract][Full Text] [Related]
25. Review of amikacin usage in the EORTC trials.
Zinner SH
Am J Med; 1985 Jul; 79(1A):17-20. PubMed ID: 3895903
[TBL] [Abstract][Full Text] [Related]
26. Single-agent therapy for infections in neutropenic cancer patients.
Fainstein V; Bodey GP
Am J Med; 1985 Aug; 79(2A):83-8. PubMed ID: 3895923
[TBL] [Abstract][Full Text] [Related]
27. Monotherapy for empiric treatment of fever in granulocytopenic cancer patients.
Wade JC; Johnson DE; Bustamante CI
Am J Med; 1986 May; 80(5C):85-95. PubMed ID: 3521273
[TBL] [Abstract][Full Text] [Related]
28. Neutropenia, fever, and infection.
Brown AE
Am J Med; 1984 Mar; 76(3):421-8. PubMed ID: 6702873
[TBL] [Abstract][Full Text] [Related]
29. Aztreonam therapy in neutropenic patients with cancer.
Jones PG; Rolston KV; Fainstein V; Elting L; Walters RS; Bodey GP
Am J Med; 1986 Aug; 81(2):243-8. PubMed ID: 3526885
[TBL] [Abstract][Full Text] [Related]
30. [Prevention of bacterial and fungal infections in neutropenic patients with malignant hematologic diseases].
Candoni A; Russo D; Salmaso F
Clin Ter; 1997; 148(1-2):23-8. PubMed ID: 9377834
[TBL] [Abstract][Full Text] [Related]
31. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
Rotstein C; Cimino M; Winkey K; Cesari C; Fenner J
Am J Med; 1988 Jul; 85(1A):36-43. PubMed ID: 3041817
[TBL] [Abstract][Full Text] [Related]
32. Empirical antibiotic therapy in febrile patients with neutropenia and malignant disease.
Tattersall MH; Hutchinson RM; Gaya H; Spiers AS
Eur J Cancer (1965); 1973 Jun; 9(6):417-23. PubMed ID: 4372049
[No Abstract] [Full Text] [Related]
33. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
34. Empiric therapy for bacterial infections in neutropenic patients.
Klastersky J
Cancer Treat Res; 1995; 79():101-12. PubMed ID: 8746651
[No Abstract] [Full Text] [Related]
35. Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutropenic patient.
Louie TJ; Chubb H; Bow EJ; Conly JM; Harding GK; Rayner E; James M
Rev Infect Dis; 1985; 7 Suppl 4():S747-61. PubMed ID: 3909333
[TBL] [Abstract][Full Text] [Related]
36. The use of aminoglycosides in neutropenic patients.
Cometta A; Glauser MP
Schweiz Med Wochenschr Suppl; 1996; 76():21S-27S. PubMed ID: 8677415
[TBL] [Abstract][Full Text] [Related]
37. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N
Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic treatment of febrile episodes in neutropenic cancer patients. Clinical and economic considerations.
de Lalla F
Drugs; 1997 May; 53(5):789-804. PubMed ID: 9129866
[TBL] [Abstract][Full Text] [Related]
39. Aztreonam in the prevention and treatment of infection in neutropenic cancer patients.
Rolston KV; Bodey GP; Elting L
Am J Med; 1990 Mar; 88(3C):24S-29S; discussion 38S-42S. PubMed ID: 2180294
[TBL] [Abstract][Full Text] [Related]
40. Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.
Hathorn JW; Rubin M; Pizzo PA
Antimicrob Agents Chemother; 1987 Jul; 31(7):971-7. PubMed ID: 3310871
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
